Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy | MicrobiomeTrials← Back to trialsNCT05070351
Deprescribing Proton Pump Inhibitors to Reduce Post-TIPS Hepatic Encephalopathy
CompletedPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2022-01-03Est. Completion: 2025-06-02
Enrollment target: 33 participants Locations- Duke University Hospital, Durham, North Carolina, United States
Other microbiome trials you might be interested in
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031
Cirrhosis, LiverSplenectomy; StatusRenal Function AbnormalPortal Hypertension
Patients with liver cirrhosis and portal hypertension often have impaired kidney function due to reduced blood flow to t…
Multiple LocationsCompleted Feb 2026